Jonathan Thomas, PhD, JD, is President and CEO of the California Institute for Regenerative Medicine (CIRM). Thomas was previously the Chair of the CIRM governing Board from June 2011 to March 2023.

The simple term “stem cell” actually refers to many different types of cells. The tissue-specific stem cells, or adult stem cells, replenish tissues throughout our lives. Embryonic stem cells exist ...

A major challenge in developing stem cell-based cures for disease is maturing those cells into adult cell types that can be used for transplantation or to study human disease. Dr. Mark Mercola has a ...

At meetings of the CIRM governing board, patients, clinicians and researchers speak about the hope of stem cell research for a particular disease area. These are their stories.

Earl J. Beadle Productions, Inc. Stem cells have the potential to treat a wide range of diseases, but developing those cures is a process that has many hurdles. Dr. Hans Keirstead has a CIRM grant to ...

Embryonic stem cells have the potential to help treat 70 or more diseases, but developing those new therapies will take time. Alan Lewis is the former president and CEO of Novocell (now ViaCyte), a La ...

The signaling protein Wnt7a has been implicated in ensuring nerve cells called neurons reach their correct targets and in the formation of synapses between neurons; however studies of the role of ...

As part of our CIRM Roadshow, we are holding a series of meetings throughout the state, in order to re-introduce you to CIRM and what this radical new stemcelerating machine can do. Please join us for ...

Las reuniones de la CFAOC están organizadas por la Oficina del Contralor del Estado. A continuación, se incluye una copia de la agenda publicada en https://www.sco ...

https://im.csgsystems.com/cgi-bin/confCast Enter Conference ID# 457698 Then click Go. 3. Discussion of Personnel [Evaluation of President] (Government Code section ...

Primary immunodeficiencies are disease that compromise or destroy the immune system, leaving patients susceptible to serious infections. Typically, these diseases have genetic causes and many of them ...

Stephen Juelsgaard, DVM, JD, is the former executive vice president, secretary, and chief compliance officer of Genentech, Inc. In that role, Mr. Juelsgaard reported to Genentech’s CEO, Art Levinson, ...